Can-Fite BioPharma American Depositary Shares
CANF
11 hedge funds and large institutions have $1.05M invested in Can-Fite BioPharma American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
4% less capital invested
Capital invested by funds: $1.09M → $1.05M (-$47.3K)
15% less funds holding
Funds holding: 13 → 11 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$230K |
| 2 |
SG
StoneX Group
New York
|
+$87.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$17.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$114K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$96.1K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$46.9K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$28K |
| 5 |
Jane Street
New York
|
-$26K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $421K | +$230K | +525 | +132% |
|
|
CAN
2
Cetera Advisor Networks
El Segundo,
California
| $359K | -$5.7K | -13 | -2% |
|
|
SG
3
StoneX Group
New York
| $91K | +$87.7K | +200 | New |
|
|
4
Citadel Advisors
Miami,
Florida
| $88K | -$46.9K | -107 | -36% |
|
5
Stifel Financial
St. Louis,
Missouri
| $27K | – | – | – |
|
|
TSS
6
Two Sigma Securities
New York
| $23K | -$96.1K | -219 | -81% |
|
|
7
UBS Group
Zurich,
Switzerland
| $18K | +$17.1K | +39 | New |
|
8
Citigroup
New York
| $13K | – | – | – |
|
9
Wells Fargo
San Francisco,
California
| $3K | – | – | – |
|
|
APA
10
American Portfolios Advisors
Holbrook,
New York
| $2.51K | – | – | – |
|
|
FDCDDQ
11
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $1.22K | – | – | – |
|
|
VF
12
Virtu Financial
New York
| – | -$114K | -231 | Closed |
|
|
XT
13
XTX Topco
George Town,
Cayman Islands
| – | -$28K | -56 | Closed |
|
|
14
Jane Street
New York
| – | -$26K | -53 | Closed |
|
CANF Hedge Fund Activity: Q2 2021 in Review
11 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q2 2021, worth a combined $1.05M — down 4.3% from $1.09M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CANF and 2 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Morgan Stanley, adding an estimated $230K. The largest seller was Virtu Financial, exiting entirely with an estimated $114K sold.
- 11 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q2 2021, down from 13 in Q1 2021.
- Funds reported $1.05M of Can-Fite BioPharma American Depositary Shares stock for Q2 2021, down 4.3% quarter-over-quarter.
- 2 funds opened new Can-Fite BioPharma American Depositary Shares positions in Q2 2021 and 4 closed out, a net change of -2 holders.
- The largest Can-Fite BioPharma American Depositary Shares buyer in Q2 2021 was Morgan Stanley, an estimated $230K added.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q2 2021 was Virtu Financial, an estimated $114K sold.
Based on aggregated 13F filings for Q2 2021.